Zdrowie i gospodarka · 19/06/2007

FDA Finalizes Donor Screening and Testing Rule for Human Cells, Tissues, and Cellular and Tissue-Based Products

The Food and Drug Administration (FDA) is adopting the final rule for donor screening and testing of human cells, tissues, and cellular and tissue-based products (HCTPs), and related labeling, without any changes to the interim final rule. This completes the rulemaking process initiated by the interim final rule.